Pfizer CentreOne Header Pfizer CentreOne Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Quoin Pharmaceuticals

    Client Virtual Booth

    QUOIN PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Quoin Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    42127 Pleasant Forest Court Ashburn​, VA, 20148-7349
    Telephone
    Telephone
    (703) 980-4182
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://quoinpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/quoin-pharmaceuticals/?trk=ppro_cprof&originalSubdomain=uk
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Quoin Provides Corporate Update and Announces Q2 2023 Financial Results
    Quoin Provides Corporate Update and Announces Q2 2023 Financial Results

    https://www.globenewswire.com/news-release/2023/08/02/2717459/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Announces-Second-Quarter-2023-Financial-Results.html

    GLOBENEWSWIRE
    02 Aug 2023
    Share Share
    Quoin Pharmaceuticals Announces Second Quarter 2023 Financial Results
    Quoin Pharmaceuticals Announces Second Quarter 2023 Financial Results

    https://www.globenewswire.com/news-release/2023/07/27/2712134/0/en/Quoin-Pharmaceuticals-Announces-Second-Quarter-2023-Financial-Results-and-Corporate-Update-Conference-Call-to-be-held-on-Thursday-August-3rd-at-8-30-am-ET.html

    GLOBENEWSWIRE
    27 Jul 2023
    Share Share
    Quoin Pharma Announces 50% Enrollment in Open Label Netherton Syndrome Trial
    Quoin Pharma Announces 50% Enrollment in Open Label Netherton Syndrome Trial

    https://www.globenewswire.com/news-release/2023/05/24/2675214/0/en/Quoin-Pharmaceuticals-Announces-50-Enrollment-in-Open-Label-Netherton-Syndrome-Clinical-Trial.html

    GLOBENEWSWIRE
    24 May 2023
    Share Share
    Quoin Pharmaceuticals Provides Corporate Update and Announces 1Q 2023 FYR
    Quoin Pharmaceuticals Provides Corporate Update and Announces 1Q 2023 FYR

    https://www.globenewswire.com/news-release/2023/05/08/2663918/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Announces-First-Quarter-2023-Financial-Results.html

    GLOBENEWSWIRE
    08 May 2023
    Share Share
    Quoin Pharmaceuticals Announces 1Q 2023 FYR and Corporate Update Conference Call
    Quoin Pharmaceuticals Announces 1Q 2023 FYR and Corporate Update Conference Call

    https://www.globenewswire.com/news-release/2023/05/02/2659173/0/en/Quoin-Pharmaceuticals-Announces-First-Quarter-2023-Financial-Results-and-Corporate-Update-Conference-Call-to-Be-Held-on-Tuesday-May-9-2023-at-8-30-am-ET.html

    GLOBENEWSWIRE
    02 May 2023
    Share Share
    Quoin Doses First Patient in Open Label Netherton Syndrome Clinical Trial
    Quoin Doses First Patient in Open Label Netherton Syndrome Clinical Trial

    https://www.globenewswire.com/news-release/2023/03/21/2631293/0/en/Quoin-Pharmaceuticals-Doses-First-Patient-in-Open-Label-Netherton-Syndrome-Clinical-Trial.html

    GLOBENEWSWIRE
    21 Mar 2023
    Share Share
    Quoin Pharmaceuticals Announces 2022 Corporate Update Conference Call
    Quoin Pharmaceuticals Announces 2022 Corporate Update Conference Call

    https://www.globenewswire.com/news-release/2023/03/02/2619825/0/en/Quoin-Pharmaceuticals-Announces-2022-Corporate-Update-Conference-Call-to-be-held-on-Thursday-March-9th-at-8-30am-ET.html

    GLOBENEWSWIRE
    02 Mar 2023
    Share Share
    Quoin Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
    Quoin Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

    https://www.globenewswire.com/news-release/2023/02/22/2613258/0/en/Quoin-Pharmaceuticals-Announces-Pricing-of-7-0-Million-Public-Offering.html

    GLOBENEWSWIRE
    22 Feb 2023
    Share Share
    Quoin Announces Dosing of First Patient in Trial in Netherton Syndrome
    Quoin Announces Dosing of First Patient in Trial in Netherton Syndrome

    https://www.globenewswire.com/news-release/2022/12/13/2572763/0/en/Quoin-Pharmaceuticals-Announces-Dosing-of-First-Patient-in-Clinical-Trial-in-Netherton-Syndrome.html

    GLOBENEWSWIRE
    13 Dec 2022
    Share Share
    Quoin Announces Updated Timing of Q3 2022 Corporate Update Conference
    Quoin Announces Updated Timing of Q3 2022 Corporate Update Conference

    https://www.globenewswire.com/news-release/2022/11/03/2547395/0/en/Quoin-Pharmaceuticals-Announces-Updated-Timing-of-Third-Quarter-2022-Corporate-Update-Conference-Call-to-be-held-on-Thursday-November-10th.html

    GLOBENEWSWIRE
    03 Nov 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    lgm-pharma-2023-09-18

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search